Andrew Lawrence Taylor, Chief Financial Officer of Orchestra BioMed Holdings, Inc., filed a Form 4 on November 20, 2026, reporting the withholding of shares by the issuer to satisfy tax obligations connected to the vesting of restricted stock units.
Key Highlights
- Reporting person: Andrew Lawrence Taylor, Chief Financial Officer of Orchestra BioMed Holdings, Inc.
- Transaction date: November 20, 2026, with transaction code F (tax withholding).
- Shares withheld: 3,076 shares of Common Stock, par value $0.0001 per share, disposed of at $6.58 per share.
- Post-transaction ownership: Taylor directly beneficially owned 587,913 shares following the reported transaction.
- No market sale: According to the filing, "No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations."
Orchestra BioMed CFO Reports RSU Tax Withholding Transaction
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) CFO Andrew Lawrence Taylor reported a single non-derivative securities transaction on November 20, 2026. According to the filing, the transaction involved the withholding of 3,076 shares of Orchestra BioMed common stock by the issuer at a price of $6.58 per share. The filing identifies the transaction code as F, which corresponds to shares withheld for tax withholding purposes.
The filing states that the disposition represented shares withheld by the issuer "to satisfy tax withholding obligations in connection with vesting of restricted stock units." The filing further clarifies that no shares were sold on the open market in connection with this event. Following the transaction, Taylor held 587,913 shares of common stock directly. The filing was made by one reporting person and was not indicated as an amendment to a prior form.
Taylor's address is listed as c/o Orchestra BioMed Holdings, Inc., 150 Union Square Drive, New Hope, Pennsylvania 18938. The filing was signed on November 20, 2026. No derivative securities transactions were reported in Table II of the form.
What Was Disclosed
Orchestra BioMed's CFO filed a Form 4 disclosing the issuer's withholding of 3,076 common shares at $6.58 to cover RSU-related tax obligations on November 20, 2026, leaving Taylor with direct beneficial ownership of 587,913 shares.



Please wait processing your request...